Editorial · 31 Aug 2023
Mini reviewPublished 31 Aug 2023
Enzymes and Drug Targets: Current Advances and Future Perspectives
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Enzymes play pivotal roles in various cellular processes, making them attractive targets for drug development. Over the years, significant advances have been made in the identification and characterization of enzymes as potential drug targets. This review explores the current state of knowledge on enzymes as drug targets, highlighting recent developments in enzyme-targeted therapeutics and the challenges in drug discovery and development. We discuss the intricacies of enzyme inhibition, allosteric regulation, and modulatory mechanisms that influence drug efficacy and selectivity. Moreover, we delve into the emerging technologies and approaches, such as computational modeling and high-throughput screening that have revolutionized the identification of novel enzyme targets. Furthermore, we explore the potential of personalized medicine in enzyme-targeted therapies, emphasizing the importance of considering individual variability in drug response. Finally, we envision future perspectives and opportunities for exploiting enzymes as effective and tailored drug targets to address unmet medical needs and improve patient outcomes. The integration of cutting-edge research and innovative strategies promises to unlock new horizons in drug development and usher in a new era of precision medicine. Keywords Computational modeling; personalized medicine; Precision medicine; Drug efficacy
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Molecular Enzymology and Drug Targets.
Editorial · 31 Aug 2023
Beyond the Norm: Unraveling Non-competitive Inhibition in Enzyme Kinetics and Drug Development
Editorial · 31 Aug 2023
Targeting the Achilles Heel: Cancer Drug Targets for Precision Therapies
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular Enzymology and Drug Targets
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ashutosh Mukharji”
